Publications by authors named "T Ichimiya"

We describe a case of familial Mediterranean fever (FMF) with sigmoid colon stricture. The patient, a woman in her 30 s, had a 12-year history of ileocolitis-type Crohn's disease. The colonoscope could not pass because of the sigmoid colon stricture, and the patient was referred to our hospital with complaints of abdominal pain and fever.

View Article and Find Full Text PDF

Background: Inflammatory bowel disease (IBD) is a chronic intestinal disorder characterized by recurrent flare-ups and remission. Leucine-rich α2-glycoprotein (LRG) has been developed as a new serum biomarker of disease activity in patients with IBD. However, there have been no reports on whether plasma LRG can be used as an alternative to serum LRG.

View Article and Find Full Text PDF

We evaluated whether texture and color enhancement imaging (TXI) using a high-definition ultrathin transnasal endoscope (UTE) improves the visibility of early gastric cancer (EGC) compared with white-light imaging (WLI). This study included 31 EGCs observed by TXI mode 2 using a high-definition UTE prior to endoscopic submucosal dissection. The first outcome was to compare the color differences based on Commission Internationale de l'Eclairage L*a*b* color space between EGCs and the surrounding mucosa by WLI and TXI using the UTE (objective appearance of EGC).

View Article and Find Full Text PDF
Article Synopsis
  • Glycosaminoglycans (GAGs) are polysaccharides on cell surfaces, playing key roles in growth factor signaling, with variations in their sulfation impacting function.
  • The study focused on cochlins, proteins that bind sulfated GAGs, using a recombinant cochlin to identify specific binding to heparan sulfate and chondroitin sulfate E.
  • By analyzing cochlin mutants, the research developed a GAG detection system, revealing that the N-terminal of cochlin is crucial for binding, which may advance understanding of disease mechanisms related to GAG modifications.
View Article and Find Full Text PDF

Late-onset non-syndromic autosomal dominant hearing loss 9 (DFNA9) is a hearing impairment caused by mutations in the coagulation factor C homology gene (COCH). COCH encodes for cochlin, a major component of the cochlear extracellular matrix. Though biochemical and genetic studies have characterized the properties of wild-type and mutated cochlins derived from DFNA9, little is known about the underlying pathogenic mechanism.

View Article and Find Full Text PDF